The NIH has scaled back its awards of new grants by at least $2.3 billion since the beginning of the year, a STAT analysis ...

A spokesperson said Thursday that "NIH initially exceeded its internal targets for contract reductions" in explaining the ...

The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...

STAT is tracking, day by day, what's happened in the words of science and health during the first months of the Trump ...

A former FDA commissioner and a former Institute of Medicine president are teaming up to create the Vaccine Integrity Project ...

The federal health department is not creating a new registry of Americans with autism, an HHS official said Thursday.

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

More than a dozen states are seeking federal permission to add work requirements to their Medicaid programs. Three states — ...

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...

In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...